Cor Vasa 2023, 65(5):798-805 | DOI: 10.33678/cor.2023.057

(Czech Association for Preventive Cardiology Expert Consensus Statement on the State of Genetic Testing for Inherited Cardiovascular Diseases)

Alice Krebsováa, Eva Kutílkováa, Veronika Zoubkováb, Terezia Tavačovác, Petra Peldováb, Lenka Piherovád, Pavel Votýpkab, Štěpánka Pohlová Kučerováe, Ilga Grochováf, Andrea Gřegořovág, Daniela Žákováh, Tomáš Freibergerh, Jan Janoušekc, Tomáš Novotnýi, Milan Macekb
a Centrum dědičných kardiovaskulárních onemocnění, Klinika kardiologie, Institut klinické a experimentální medicíny, Praha, ERN GUARD-Heart
b Ústav biologie a lékařské genetiky, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha, ERN ITHACA
c Dětské kardiocentrum, 2. lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Motol, Praha, ERN GUARD-Heart
d Klinika dětí a dorostu, 1. lékařská fakulta Univerzity Karlovy a Všeobecná fakultní nemocnice v Praze, Praha
e Ústav soudního lékařství, Lékařská fakulta Univerzity Karlovy a Fakultní nemocnice Hradec Králové, Hradec Králové
f I. interní kardioangiologická klinika, Fakultní nemocnice u sv. Anny v Brně a Centrum prenatální diagnostiky Brno, Brno
g Ústav klinické a molekulární patologie a lékařské genetiky (ÚKMPLG), Fakultní nemocnice Ostrava, Ostrava
h Lékařská fakulta Masarykovy univerzity a Centrum kardiovaskulární a transplantační chirurgie Brno, Brno
i Interní kardiologická klinika, Lékařská fakulta Masarykovy univerzity a Fakultní nemocnice Brno, Brno

In contemporary cardiology, genetics is mainly applied to cardiovascular diseases with Mendelian inheritance. These diseases include cardiomyopathy, hereditary forms of arrhythmic syndromes, aortic syndromes, and some congenital developmental defects. The common risk of all mentioned groups of diseases is sudden cardiac death, which is why post-mortem examination and care for relatives and survivors are an important part.

The goal of clinical genetic examination and genetic counselling in cardiology is to carry out a detailed description of the disease - phenotyping, compiling a family tree, cascade cardiology screening in the family and, in indicated cases, molecular genetic diagnosis - genotyping.

Keywords: Genetic analysis, Family cascade screening, Inherited cardiovascular diseases, Knowledge of the molecular nature of genetic diseases opens up the possibilities of the so-called molecular genetic stratification of diseases, the goal of which is personalized care for patients and their relatives. Cardiogenetic examination is a complex matter, where it is necessary to build interdisciplinary teams. Communication between individual experts and teams on a national scale is absolutely essential to ensure care for patients with rare and very rare forms of hereditary disease.

Received: June 27, 2023; Revised: June 27, 2023; Accepted: July 16, 2023; Published: October 15, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Krebsová A, Kutílková E, Zoubková V, Tavačová T, Peldová P, Piherová L, et al.. (Czech Association for Preventive Cardiology Expert Consensus Statement on the State of Genetic Testing for Inherited Cardiovascular Diseases). Cor Vasa. 2023;65(5):798-805. doi: 10.33678/cor.2023.057.
Download citation

References

  1. Wilde AAM, Semsarian C, Márquez MF, et al. European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia
  2. Isbister JC, Nowak N, Butters A, et al. "Concealed cardiomyopathy" as a cause of previously unexplained sudden cardiac arrest. Int J Cardiol 2021;324:96-101. Go to original source... Go to PubMed...
  3. Stiles MK, Wilde AAM, Abrams DJ, et al. 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families. Heart Rhythm 2021;18:e1-e50. Go to original source... Go to PubMed...
  4. Verhagen JMA, Kempers M, Cozijnsen L, et al. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives. Int J Cardiol 2018;258:243-248. Go to original source... Go to PubMed...
  5. Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013;34:3478-3490a. Go to original source... Go to PubMed...
  6. Rapezzi C, Arbustini E, Caforio AL, et al. Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:1448-1458. Go to original source... Go to PubMed...
  7. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022;43:3997-4126. Go to original source... Go to PubMed...
  8. Charron P, Arad M, Arbustini E, et al. Genetic counselling and testing in cardiomyopathies: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010;31:2715-2728. Go to original source... Go to PubMed...
  9. Basso C, Burke M, Fornes P, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Archiv 2008;452:11-18. Go to original source... Go to PubMed...
  10. Zeman M, Kučerová ŠP, Vojtíšek T, et al. Standard autopsy and diagnostic procedure in forensic departments in cases of sudden cardiac death (SCD) in individuals under 40 years of age. Soud Lek 2023;68:2-10.
  11. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-424. Go to original source... Go to PubMed...
  12. Adler A, Novelli V, Amin AS, et al. An International, Multicentered, Evidence-Based Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome. Circulation 2020;141:418-428. Go to original source... Go to PubMed...
  13. Salfati EL, Spencer EG, Topol SE, et al. Re-analysis of whole- -exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases. Genome Med 2019;11:83. Go to original source... Go to PubMed...
  14. Campuzano O, Sarquella-Brugada G, Fernandez-Falgueras A, et al. Reanalysis and reclassification of rare genetic variants associated with inherited arrhythmogenic syndromes. EBioMedicine 2020;54:102732. Go to original source... Go to PubMed...
  15. Quiat D, Witkowski L, Zouk H, et al. Retrospective analysis of clinical genetic testing in pediatric primary dilated cardiomyopathy: Testing outcomes and the effects of variant reclassification. J Am Heart Assoc 2020;9:e016195. Go to original source... Go to PubMed...
  16. Fellmann F, van El CG, Charron P, et al. European recommendations integrating genetic testing into multidisciplinary management of sudden cardiac death. Eur J Hum Genet 2019;27:1763-1773. Go to original source... Go to PubMed...
  17. Bos JM, Will ML, Gersh BJ, et al. Characterization of a phenotype-based genetic test prediction score for unrelated patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2014;89:727-737. Go to original source... Go to PubMed...
  18. Escobar-Lopez L, Ochoa JP, Royuela A, et al. Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy. J Am Coll Cardiol 2022;80:1115-1126. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.